Is Smoking Associated with Alcohol-Drug Dependence in Patients with Pain and Chronic Pain Patients? An Evidence-Based Structured Review

Pain Medicine (United States)

Volumn 13, Issue 9, 2012, Pages 1212-1226

  Fishbain, David A ^a,b,c,d   Cole, Brandly ^c   Lewis, John E ^a   Gao, Jinrun ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c The Rosomoff Comprehensive Pain Center A department of Douglas Gardens Hospital   (United States)

^d State Farm Insurance   (United States)

Author keywords

Alcohol dependence; Chronic pain; Drug dependence; Opioid dependence; Review; Smoking

Indexed keywords

OPIATE;

ADDICTION; ADVERSE OUTCOME; ALCOHOLISM; ANALGESIA; ARTICLE; CALCULATION; CHRONIC PAIN; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; HUMAN; OPIATE ADDICTION; SCORING SYSTEM; SMOKING;

EID: 84866293531     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01446.x     Document Type: Review

References (69)

1. Breslau N, Johnson E, Hiripi E, Kessler R. Nicotine dependence in the United States. Arch Gen Psychiatry 2001;58:810-6.
2. Hughes JR, Helzer JE, Lindberg SA. Prevalence of DSM/ICE-defined nicotine dependence. Drug Alcohol Depend 2006;85(2):91-102.
3. Bien TH, Burge R. Smoking and drinking: A review of the literature. Int J Addict 1990;25(12):1429-54.
4. DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alcohol 1990;31(2):130-5.
5. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the USA. Results from the National Epidemiological Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:1107-14.
6. Romberger DJ, Grant K. Alcohol consumption and smoking status. The role of smoking cessation. Biomed Pharmacother 2004;8(2):77-83.
7. Benowitz NL. Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009;49:57-71.
8. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005;14(2):106-23.
9. Jane-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006;25(6):515-36.
10. Henningfield JE, Clayton R, Pollin W. Involvement of tobacco in alcoholism and illicit drug use. Br J Addict 1990;85(2):279-91.
11. Henningfield JE, Griffiths RR, Jasinski DR. Human dependence on tobacco and opioids: Common factors. NIDA Res Monogr 1981;37:210-34.
12. Berger H, Schweigler M. Smoking characteristics of methadone patients. JAMA 1972;222:705.
13. Chait LD, Griffiths RR. Effects of methadone on human cigarette smoking and subjective ratings. J Pharmacol Exp Ther 1984;229:636-40.
14. Stark MJ, Campbell BK. Cigarette smoking and methadone dose levels. Am J Drug Alcohol Abuse 1993;19:209-17.
15. Shoptaw S, Jarvik ME, Ling W, Rawson RA. Contingency management of tobacco smoking in methadone-maintained opiate addicts. Addict Behav 1996;21:409-12.
16. Frosch DL, Shoptaw S, Jarvik ME, Rawson RA, Ling W. Preliminary experiences with opiate abusers seeking smoking cessation treatment. Paper presented at the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence, Nashville, TN, 1997.
17. Frosch DL, Nahom D, Shoptaw S, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol 2000;8(1):97-103.
18. Coambs RB, Jarry JL. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manag 1996;1:155-62.
19. Fishbain DA, Lewis JE, Cole B, etal. Variables associated with current smoking status in chronic pain patients. Pain Med 2007;8(4):301-11.
20. Dhingra LK, Passik SD. Smoking and aberrant behavior in chronic pain patients. Pract Pain Manag 2007;Sept.:34-8.
21. Antonov KK, Isacson DD. Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother 1998;32(4):485-94.
22. Antonov KK, Isacson DD. Use of analgesics in Sweden-The importance of sociodemographic factors, physical fitness, health and health-related factors, and working conditions. Soc Sci Med 1996;42(11):1473-81.
23. Michna E, Ross EL, Hynes WL, etal. Predicting aberrant drug behaviors in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28(3):250-8.
24. Agency for Healthcare Research and Quality. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment #47. AHRQ Publication No. 02-EO16, April 2002.
25. Friedman R, Li V, Mehrotra D. Treating patients at risk: Evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 2003;4(2):182-5.
26. Barton SB, Kofoed BA, Doleys DM. Smoking and narcotics use among chronic pain patients. Psychol Rep 1989;64:1253-4.
27. Stover BD, Turner JA, Franklin G, etal. Factors associated with early opioid prescription among workers with low back injuries. J Pain 2006;7(10):718-25.
28. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg 2009;108(1):308-15.
29. Krebs EE, Lurie JD, Fanciullo G, etal. Predictors of long-term opioid use among patients with painful lumbar spine conditions. J Pain 2010;11(1):44-52.
30. Cox BD, Prevost AT, Whichelow MJ. Associations of smoking with prescribed medications, arthritis/rheumatism and back problems in British Health and Lifestyle Survey follow-up respondents. Eur J Public Health 1997;7(3):311-7.
31. Ackerman WE 3rd, Ahmad M. Effect of cigarette smoking on serum hydrocodone levels in chronic pain patients. J Ark Med Soc 2007;104(1):19-21.
32. Creekmore FM, Lugo RA, Weiland KJ. Postoperative opiate analgesia requirements of smokers and nonsmokers. Ann Pharmacother 2004;38(6):949-53.
33. Hooten WM, Shi Y, Gazelka HM, Warner DO. The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain 2011;152(1):223-9.
34. Højsted J, Nielsen RR, Guldstrand SK, Frich L, Sjøgren P. Classification and identification of opioid addiction in chronic pain patients. Eur J Pain 2010;14:1014-20.
35. Broekmans S, Dobbels F, Milisen K, Morlion B, Vanderschueren S. Pharmacologic pain treatment in a multidisciplinary pain center: Do patients adhere to the prescription of the physician? Clin J Pain 2010;26(2):81-6.
36. Barry DT, Goulet JL, Kerns RK, etal. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain 2011;152(5):1133-8.
37. Ekholm O, Grønbaek M, Peuckmann V, Sjøgren P. Alcohol and smoking behavior in chronic pain patients: The role of opioids. Eur J Pain 2009;13:606-12.
38. Hoogendoorn WE, van Poppel MN, Bongers PM, Koes BW, Bouter LM. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine (Phila Pa 1976) 2000;25:2114-25.
39. De Vet H, De Bie R, van der Heijden G, etal. Systematic review of basis of methodological criteria. Physiotherapy 1997;83:284-9.
40. Borghouts JA, Koes BW, Bourter LM. The clinical course and prognostic factors of non-specific neck pain: A systematic review. Pain 1998;77:1-13.
41. Weingarten TN, Moeschler SM, Ptaszynski AE, etal. An assessment of the association between smoking status, pain intensity, and functional interference in patients with chronic pain. Pain Physician 2008;5:643-53.
42. Yunis MB, Arslan S, Aldag JC. Relationship between fibromyalgia features and smoking. Scand J Rheumatol 2002;31(5):301-5.
43. Weingarten TN, Podduturu VR, Hooten WW, etal. Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment for fibromyalgia. Clin J Pain 2009;25(1):39-43.
44. Biala G, Budzynska B, Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine induced antinociception in mice. Pharmacol Rep 2005;57(6):755-60.
45. Natase A, Ioan S, Braga RI, Zagrean L, Moldovan M. Coffee drinking enhances the analgesic effect of cigarette smoking. Neuroreport 2007;18(9):921-4.
46. Al'Absi M, Wittners LE, Hatsukami D, Westra R. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke. Psychosom Med 2008;70(8):928-35.
47. Ditre JW, Brandon TH. Pain as a motivator of smoking: Effects of pain inductor on smoking urge and behavior. J Abnorm Psychol 2008;117(2):467-72.
48. John U, Alte D, Hanke M, etal. Tobacco smoking in relation to analgesic drug use in a national adult population sample. Drug Alcohol Depend 2006;85(1):49-55.
49. Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A. Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study. Ann Epidemiol 2010;20(12):890-7.
50. Log T, Hartz I, Tverdal A, Furu K, Skurtveit S. The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults-A population-based cohort study. Pharmacoepidemiol Drug Saf 2011;20(1):90-8.
51. Eggen AE. The Tromso study: Frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). J Clin Epidemiol 1993;46(11):1297-304.
52. Fishbain DA, Lewis JE, Gao J. Case report: Allegations of medical malpractice in chronic opioid analgesic therapy possibly related to collaborative/split treatment and the P-450 enzyme system: Forensic case report. Pain Med 2010;11:1419-25.
53. Fishbain DA, Fishbain DC, Cutler B, etal. Genetic testing for enzymes of drug metabolism: Does it have clinical utility for pain medicine at the present time? A structured review. Pain Med 2004;5(1):83-95.
54. Anonymous. Boston Collaborative Drug Surveillance Program. Decreased clinical efficacy of propoxyphene in cigarette smokers. Clin Pharmacol Ther 1973;14(2):259-63.
55. Vaughn DP, Beckett AH, Robbie DS. The influence of smoking on the intersubject variation in pentazocine elimination. Br J Clin Pharmacol 1976;3(2):279-83.
56. Keeri-Szanto M, Pomeroy JR. Atmospheric pollution and pentazocine metabolism. Lancet 1971;1(7706):947-9.
57. Schlaepfer IR, Hoft NR, Ehringer MA. The genetic components of alcohol and nicotine co-addiction: From genes to behavior. Curr Drug Abuse Rev 2008;1(2):124-34.
58. Bierut LJ, Schuckit MA, Hesselbrock V, Reich T. Co-occurring risk factors for alcohol dependence and habitual smoking. Alcohol Res Health 2000;24(4):233-41.
59. Madden PA, Heath AC. Shared genetic vulnerability in alcohol and cigarette use and dependence. Alcohol Clin Exp Res 2002;26(12):1919-21.
60. Grucza RA, Bierut LJ. Co-occurring risk factors for alcohol dependence and habitual smoking: Update on findings from the collaborative study on the genetics of alcoholism. Alcohol Res Health 2006;29(3):172-8.
61. Kuhn S, Gallinat J. Common biology of craving across legal and illegal drugs-A quantitative meta-analysis of cue-reactivity brain response. Eur J Neurosci 2011;33(7):1318-26.
62. Coggins CR, Murrelle EL, Carchman RA, Heidbreder C. Light and intermittent cigarette smokers: A review (1989-2009). Psychopharmacology (Berl) 2009;207(3):343-63.
63. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between smoking and low back pain: A meta-analysis. Am J Med 2010;123(1):87.e7-35.
64. Difranza J, Ursprung WW, Lauzon B, etal. A systemic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict Behav 2010;35(5):373-82.
65. Covey LS. Tobacco cessation among patients with depression. Prim Care 1999;26(3):691-706.
66. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients; preliminary validation of the opioid risk tool. Pain Med 2005;6(6):432-42.
67. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75.
68. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain 2008;9(4):360-72.
69. Portenoy RK. Opioid therapy for chronic non-malignant pain: Current status. In: Fields HL, Liebeskind JC, eds. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Vol. 1. Seattle, WA: IASP Press; 1994:37-55.